Blaine Olsen, DO
Family Medicine · Pocatello, IDNPI 1922236454
Payments from drug & device makers
Across 114 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$364
- AbbVie$188
- Novo Nordisk$174
- Grifols USA, LLC$111
- Teva Pharmaceuticals USA, Inc.$103
- Lilly USA, LLC$92
- plus $958 from 24 others
What the payments were for
- Food & beverage$1,97599%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 22 | $364 |
| AbbVie(2 entities) | 10 | $188 |
| Novo Nordisk | 12 | $174 |
| Grifols USA, LLC | 6 | $111 |
| Teva Pharmaceuticals USA, Inc. | 7 | $103 |
| Lilly USA, LLC | 7 | $92 |
| Astellas Pharma US Inc | 4 | $92 |
| Myriad Women's Health, Inc. | 1 | $83 |
| GSK | 6 | $80 |
| Pfizer | 4 | $64 |
| Neurocrine Biosciences, Inc. | 3 | $62 |
| Xeris Pharmaceuticals, Inc. | 3 | $60 |
| Novartis | 3 | $50 |
| AstraZeneca | 3 | $49 |
| Medtronic | 1 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Abbott | 2 | $40 |
| Johnson & Johnson | 2 | $32 |
| Nestle Healthcare Nutrition Inc. | 2 | $32 |
| Boehringer Ingelheim | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Shield Therapeutics Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Roche Diagnostics Corporation | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $12 |
How this compares
$1,990 in reported general payments places this provider in the 80th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 45 | $137,644 |
| EliquisApixaban | 81 | $60,193 |
| MounjaroTirzepatide | 29 | $36,809 |
| JardianceEmpagliflozin | 37 | $32,524 |
| XareltoRivaroxaban | 29 | $24,296 |
| RybelsusSemaglutide | 14 | $14,186 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $10,761 |
| LinzessLinaclotide | 14 | $7,584 |
| Serevent DiskusSalmeterol Xinafoate | 12 | $4,868 |
| LantusInsulin Glargine,hum.Rec.Anlog | 17 | $3,747 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 11 | $3,394 |
| Atorvastatin Calcium | 360 | $3,106 |
| Levothyroxine Sodium | 253 | $2,768 |
| Arnuity ElliptaFluticasone Furoate | 11 | $2,403 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 11 | $2,295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $103 | $137,64445 claims |
| PfizerEliquis, Abrysvo | $64 | $63,58892 claims |
| Lilly USA, LLCMounjaro, Insulin Lispro, Olanzapine | $92 | $38,93775 claims |
| Boehringer IngelheimJardiance | $26 | $32,52437 claims |
| Johnson & JohnsonXarelto | $32 | $24,29629 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta, Shingrix | $80 | $15,45937 claims |
| Novo NordiskRybelsus | $174 | $14,18614 claims |
| AbbVieLinzess | $188 | $7,58414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 803 family medicine providers in Idaho.
Other family medicine in Pocatello
- Ronald SolbrigPocatello$62K
- Tyler MayoPocatello$22K
- Amber FrostPocatello$16K
- Brandon WestPocatello$6K
- Chance ChristensenPocatello$6K
- Andrew ThaynePocatello$5K
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.